Venetoclax- Augmented Treosulfan-Based Reduced Intensity Conditioning Before Allogeneic Stem Cell Transplantation

Clinical trial NCT07214064 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07214064
Sponsor: University Hospital Tuebingen
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

AML (Acute Myeloid Leukemia)MDS/AML MDS (Myelodysplastic Syndrome)

Start date: 2026-01-01
Primary completion: 2027-08-01
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.